Nathaniel J. Rhodes
-
- Antibiotic Use and Resistance 20
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria 17
- Pharmacology top 0.5%
- Antibiotics Pharmacokinetics and Efficacy 50
- Clinical Biochemistry top 1%
- Bacterial Identification and Susceptibility Testing 13
- Infectious Diseases top 5%
- Antimicrobial Resistance in Staphylococcus 22
-
- Pneumonia and Respiratory Infections 25
- Sepsis Diagnosis and Treatment 11
-
- Epilepsy research and treatment 7
- Co-authors
- Marc H. ScheetzSean N. AvedissianJiajun LiuJ. Nicholas O’DonnellGwendolyn PaisMichael PostelnickAlan R. HauserMichael Neely
- Journals
- Clinical Infectious Diseases (3 papers)Scientific Reports (2 papers)Antimicrobial Agents and Chemotherapy (22 papers)
- Partner nations
- United StatesAustraliaSpain
In The Last Decade
Nathaniel J. Rhodes
89 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 115
- Applied Microbiology and Biotechnology 231
- Molecular Medicine 506
- Pharmacology 936
- Clinical Biochemistry 281
- Infectious Diseases 518
Countries citing papers authored by Nathaniel J. Rhodes
This map shows the geographic impact of Nathaniel J. Rhodes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathaniel J. Rhodes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathaniel J. Rhodes more than expected).
Fields of papers citing papers by Nathaniel J. Rhodes
This network shows the impact of papers produced by Nathaniel J. Rhodes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathaniel J. Rhodes. The network helps show where Nathaniel J. Rhodes may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nathaniel J. Rhodes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 2 | |
| 6 | 2022 | 13 | |
| 7 | 2022 | 4 | |
| 8 | 2021 | 10 | |
| 9 | 2021 | 5 | |
| 10 | 2021 | 3 | |
| 11 | 2021 | 3 | |
| 12 | 2020 | 6 | |
| 13 | 2020 | 9 | |
| 14 | 2019 | 38 | |
| 15 | 2019 | 36 | |
| 16 | 2019 | 43 | |
| 17 | 2019 | 6 | |
| 18 | 2017 | 83 | |
| 19 | 2017 | 19 | |
| 20 | 2015 | 59 |
About Nathaniel J. Rhodes
Nathaniel J. Rhodes is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Pharmacology, having authored 96 papers that have together received 1.6k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (50 papers), Pneumonia and Respiratory Infections (25 papers), Antimicrobial Resistance in Staphylococcus (22 papers), Antibiotic Use and Resistance (20 papers), Antibiotic Resistance in Bacteria (17 papers), Bacterial Identification and Susceptibility Testing (13 papers), Sepsis Diagnosis and Treatment (11 papers) and Epilepsy research and treatment (7 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (231 citations), Molecular Medicine (506 citations) and Pharmacology (936 citations). Nathaniel J. Rhodes has collaborated with scholars based in United States, Australia and Spain. Frequent co-authors include Marc H. Scheetz, Sean N. Avedissian, Jiajun Liu, J. Nicholas O’Donnell, Gwendolyn Pais, Michael Postelnick, Alan R. Hauser, Michael Neely, Christine J. Kubin and Michael T. Yin. Their work appears in journals such as Clinical Infectious Diseases, Scientific Reports and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.